Reply to J.H. Kim and Y.S. Shin's Letter to the Editor re: Re: Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials

doi:10.1016/j.eururo.2026.07.015

Reply to J.H. Kim and Y.S. Shin's Letter to the Editor re: Re: Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Journal: European urology (Q1)
Published: 21 July 2026
Study design: Narrative review / expert opinion
Evidence level: Level 1, High (CEBM 1a)
Authors: David-Dan Nguyen, Borna Tadayon Najafabadi, Lauren Lin, Jethro C C Kwong, Girish S Kulkarni
PMID: 42481359
DOI: 10.1016/j.eururo.2026.07.015

Why clinicians should know about it

Picked for Urology (top studies of the week, 26 July 2026).

View on PubMed Full text at the publisher Open in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.